Aquestive Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Aquestive Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Aquestive Therapeutics Inc
Rating: 1.96966675
Author: Trendlyne DVM scores

about

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous Sys...

4.83 -0.04 (-0.82%)

127.83% Gain from 52W Low

1.2M

XNAS Volume

XNAS 17 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

5.7 / 100

Technically Bullish

73.1 / 100

1Yr Price target upside is 82%

10 analysts

Aquestive Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Aquestive Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous Sys...

127.83% Gain from 52W Low

SWOT Analysis

Aquestive Therapeutics Inc Live Price Chart